RankAlpha logo
Back to Rankings

VYNE

VYNE TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-23
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
VYNE vs peer average
32/100
VYNE vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

GRCE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $38.57M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGRCEGrace Therapeutics
VYNE
VYNE Therapeutics
GRCE
Grace Therapeutics
Grade
F
B
Momentum
36
70
Value
41
41
Sentiment
-
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs GRCE

VYNE / GRCE
Grade Position
Below peers
VYNE vs. peer average (F vs. D)
32/100
Momentum
36
GRCE
Value
41
VYNE
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VYNE
1
GRCE
Grace Therapeutics Inc Common
B
80/100
-3
2
GNTA
Genenta Science SpA ADR
F
20/100
Even
3
RNXT
RenovoRx Inc Common
D
40/100
-1
4
MIRA
MIRA Pharmaceuticals Inc Common
F
20/100
Even
5
SCYX
SCYNEXIS Inc Common
D
40/100
-1
GRCE is the first peer returned for this comparison set.